Arthritis Clinical Trials in Fort Worth, TX

35 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease	Phase 4	Janssen Research & Development, LLC	2 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	2 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	2 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	2 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	2 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	2 mi
FX Shoulder Prospective Clinical Study	—	FX Shoulder Solutions	13 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	Phase 2	Merck Sharp & Dohme LLC	13 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	13 mi
Study of GS-0272 in Participants With Rheumatoid Arthritis	Phase 1	Gilead Sciences	13 mi
RA-PRO PRAGMATIC TRIAL	Phase 3	University of Alabama at Birmingham	13 mi
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis	Phase 2	Surf Therapeutics	13 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug	Phase 3	MoonLake Immunotherapeutics AG	13 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults	Phase 1	UCB Biopharma SRL	13 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	13 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	13 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	13 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	23 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	28 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	Phase 3	Paradigm Biopharmaceuticals Ltd.	28 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee	Phase 2	Pacira Pharmaceuticals, Inc	28 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	29 mi
ConsideRAte Study - Splenic Stimulation for RA	N/A	Galvani Bioelectronics	31 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	31 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	31 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	31 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	41 mi
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	41 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	41 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease	Phase 1	Cullinan Therapeutics Inc.	41 mi
MDR - PMCF Study for Taperloc Complete Stems	—	Zimmer Biomet	41 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis	Phase 2	AstraZeneca	43 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis	Phase 3	Sun Pharmaceutical Industries Limited	43 mi
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	45 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants	Phase 1	AstraZeneca	45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.